Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jo

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
BMC Pulmonary Medicine|January 27, 2018
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registryHelen E Jo, Ian Glaspole, Yuben Moodley, et al.
Respirology (Carlton, Vic.)|August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaHelen E Jo, Lauren K Troy, Gregory Keir, et al.
Respirology (Carlton, Vic.)|July 19, 2016
Clinical impact of the interstitial lung disease multidisciplinary serviceHelen E Jo, Ian N Glaspole, Kovi C Levin, et al.
BMC Pulmonary Medicine|May 5, 2019
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF RegistryHelen E Jo, Tamera J Corte, Ian Glaspole, et al.
The European Respiratory Journal|February 25, 2017
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Christopher Grainge, et al.
Respirology (Carlton, Vic.)|January 11, 2024
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revisionJohn A Mackintosh, Gregory Keir, Lauren K Troy, et al.
The European Respiratory Journal|July 31, 2025
Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective studyYang Nan, Felder N Federico, Stephen Humphries, et al.
Internal Medicine Journal|October 27, 2023
Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costsJody M Bell, Tiffany J Dwyer, Michelle Cunich, et al.
Respirology (Carlton, Vic.)|February 7, 2025
Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated PatientsRoger M Li, Dino B A Tan, Chantalia Tedja, et al.
The European Respiratory Journal|May 9, 2020
Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosisBritt Clynick, Helen E Jo, Tamera J Corte, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
BMC Pulmonary Medicine|January 27, 2018
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registryHelen E Jo, Ian Glaspole, Yuben Moodley, et al.
Respirology (Carlton, Vic.)|August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaHelen E Jo, Lauren K Troy, Gregory Keir, et al.
Respirology (Carlton, Vic.)|July 19, 2016
Clinical impact of the interstitial lung disease multidisciplinary serviceHelen E Jo, Ian N Glaspole, Kovi C Levin, et al.
BMC Pulmonary Medicine|May 5, 2019
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF RegistryHelen E Jo, Tamera J Corte, Ian Glaspole, et al.
The European Respiratory Journal|February 25, 2017
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Christopher Grainge, et al.
Respirology (Carlton, Vic.)|January 11, 2024
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revisionJohn A Mackintosh, Gregory Keir, Lauren K Troy, et al.
The European Respiratory Journal|July 31, 2025
Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective studyYang Nan, Felder N Federico, Stephen Humphries, et al.
Internal Medicine Journal|October 27, 2023
Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costsJody M Bell, Tiffany J Dwyer, Michelle Cunich, et al.
Respirology (Carlton, Vic.)|February 7, 2025
Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated PatientsRoger M Li, Dino B A Tan, Chantalia Tedja, et al.
The European Respiratory Journal|May 9, 2020
Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosisBritt Clynick, Helen E Jo, Tamera J Corte, et al.
Pageof 6